Systemic Minoxidil for Hair Disorders in Pediatric Patients: A Safety and Tolerability Review

    Jared Marc John, Rodney Sinclair
    TLDR Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.
    This review examined the safety and tolerability of low-dose oral minoxidil (LDOM) and sublingual minoxidil (SM) in pediatric patients aged 0-12 years with hair disorders. The study retrospectively analyzed medical records of 63 patients from a specialist hair clinic. The treatments were generally well-tolerated, with mild hypertrichosis being the most common adverse event. The authors concluded that while LDOM and SM appear safe for pediatric use, larger studies are needed to determine their efficacy and optimal dosage for treating alopecia in children.
    Discuss this study in the Community →

    Research cited in this study

    18 / 18 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    10 / 10 results